Condition of first few teeth can predict future problems, earlier visits help

(COLUMBUS, Ohio) – By the time babies get their first few teeth, parents should already be  scheduling their first trip to the dentist.  In fact, according to revised guidelines from the American Academy of Pediatric Dentistry, your child should see a dentist by the time they turn one.

“The age of the first dental visit has changed somewhat over the years,” said Paul. . . read more

80% of stroke patients lose use of arm, hi-tech brace could give new hope

(COLUMBUS, Ohio) – Sabrina Pridham knows all too well how quickly life can change.  At 33, she was a successful CPA and a young, healthy mother with a sense for adventure.

In the spring of 2000, Sabrina had just buckled herself into the passenger seat of a race car to take lessons in defensive driving from a professional driver.  Then, right there on the track, it happened.  . . . read more

Researchers “stunned” by test results.  Could help 50 million Americans

(COLUMBUS, Ohio) – What started out as a plan to develop a drug to lower blood sugar in diabetics, may ultimately wind up treating two of the most-wide spread and costliest conditions in the U.S.; type 2 diabetes and heart disease.  Combined, those two diseases affect more than 50 million Americans¹ and cost a staggering $618 billion a year¹.

The prospect of trea. . . read more

New study may help explain why rates are three times higher in men

(COLUMBUS, Ohio) – Females are often called the fairer sex, but scientists have found that they may have an unfair advantage over males when it comes to battling skin cancer.  
Men are much more likely to get skin cancer than women¹ but for generations, doctors didn’t know why.

“The incidence of skin cancer in men is approximately three fold higher than in women,” said Gregory Lesinski, PhD, an assi. . . read more

Doctors study heart cells during chemo to look for subtle signs of damage

(COLUMBUS, Ohio) – Doctors have known for decades that the drug doxorubicin can be very effective in treating breast cancer.  What they don’t know is how much damage, if any, it might do to a woman’s heart in the process.

First developed in the 1950’s, and partially named for its ruby red color, doxorubicin has long been suspected of posing a rare but significant risk for heart damage.  But when, . . . read more